EWTX Insider Transactions — Page 2
182 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–182; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Donovan Joanne M. | CMO | 2023-05-02 | Sale | 3,254.0 | $8.9 |
| KOCH KEVIN | President and CEO | 2023-05-02 | Sale | 3,203.0 | $8.9 |
| MOORE JOHN R | General Counsel | 2022-10-03 | Sale | 4,730.0 | $9.76 |
| Thompson Peter A. | Director,TenPercentOwner | 2022-09-16 | Purchase | 484,496.0 | $10.32 |
| ORBIMED ADVISORS LLC | Director,TenPercentOwner | 2022-09-16 | Purchase | 484,496.0 | $10.32 |
| OrbiMed Capital GP VI LLC | Director,TenPercentOwner | 2022-09-16 | Purchase | 484,496.0 | $10.32 |
| OrbiMed Genesis GP LLC | Director,TenPercentOwner | 2022-09-16 | Purchase | 484,496.0 | $10.32 |
| Novo Holdings A/S | TenPercentOwner | 2022-09-14 | Purchase | 484,496.0 | $10.32 |
| MOORE JOHN R | General Counsel | 2022-09-06 | Sale | 2,351.0 | $10.99 |
| MOORE JOHN R | General Counsel | 2022-09-06 | Sale | 2,379.0 | $10.83 |
| MOORE JOHN R | General Counsel | 2022-08-03 | Sale | 9,232.0 | $9.31 |
| MOORE JOHN R | General Counsel | 2022-07-06 | Sale | 1,046.0 | $8.54 |
| MOORE JOHN R | General Counsel | 2022-07-05 | Sale | 8,186.0 | $8.35 |
| MOORE JOHN R | General Counsel | 2022-06-21 | Sale | 31,078.0 | $7.29 |
| MOORE JOHN R | General Counsel | 2022-06-17 | Sale | 22,127.0 | $6.62 |
| MOORE JOHN R | General Counsel | 2022-06-16 | Sale | 14,722.0 | $6.17 |
| MOORE JOHN R | General Counsel | 2022-06-15 | Sale | 18,075.0 | $6.11 |
| MOORE JOHN R | General Counsel | 2022-06-15 | Sale | 585.0 | $6.11 |
| MOORE JOHN R | General Counsel | 2022-06-14 | Sale | 3,628.0 | $6.02 |
| MOORE JOHN R | General Counsel | 2022-06-13 | Sale | 4,093.0 | $6.01 |
| MOORE JOHN R | General Counsel | 2022-06-10 | Sale | 7,125.0 | $6.05 |
| MOORE JOHN R | General Counsel | 2022-06-09 | Sale | 7,615.0 | $6.49 |
| MOORE JOHN R | General Counsel | 2022-06-08 | Sale | 12,566.0 | $6.63 |
| MOORE JOHN R | General Counsel | 2022-06-07 | Sale | 17,150.0 | $6.61 |
| MOORE JOHN R | General Counsel | 2022-06-07 | Sale | 973.0 | $6.61 |
| MOORE JOHN R | General Counsel | 2022-06-06 | Sale | 13,934.0 | $6.03 |
| MOORE JOHN R | General Counsel | 2022-06-03 | Sale | 15,230.0 | $6.05 |
| ORBIMED ADVISORS LLC | Director,TenPercentOwner | 2022-05-18 | Purchase | 138,000.0 | $7.21 |
| OrbiMed Capital GP VI LLC | Director,TenPercentOwner | 2022-05-18 | Purchase | 138,000.0 | $7.21 |
| OrbiMed Genesis GP LLC | Director,TenPercentOwner | 2022-05-18 | Purchase | 138,000.0 | $7.21 |
| Thompson Peter A. | Director,TenPercentOwner | 2022-05-18 | Purchase | 138,000.0 | $7.21 |
| MOORE JOHN R | General Counsel | 2022-05-16 | Sale | 10,800.0 | $7.42 |
| Russell Alan J | Chief Scientific Officer | 2021-11-15 | Sale | 38.0 | $19.61 |
| Russell Alan J | Chief Scientific Officer | 2021-11-15 | Sale | 441.0 | $19.07 |
| Russell Alan J | Chief Scientific Officer | 2021-11-12 | Sale | 8,562.0 | $19.51 |
| Russell Alan J | Chief Scientific Officer | 2021-11-11 | Sale | 3,681.0 | $20.43 |
| Russell Alan J | Chief Scientific Officer | 2021-11-11 | Sale | 15,595.0 | $19.82 |
| Russell Alan J | Chief Scientific Officer | 2021-11-10 | Sale | 580.0 | $20.21 |
| Russell Alan J | Chief Scientific Officer | 2021-11-10 | Sale | 11,746.0 | $19.7 |
| Russell Alan J | Chief Scientific Officer | 2021-11-09 | Sale | 12,712.0 | $20.3 |
| Russell Alan J | Chief Scientific Officer | 2021-11-09 | Sale | 16,864.0 | $19.94 |
| Russell Alan J | Chief Scientific Officer | 2021-11-08 | Sale | 9,017.0 | $20.16 |
| Russell Alan J | Chief Scientific Officer | 2021-11-05 | Sale | 13,036.0 | $19.62 |
| Russell Alan J | Chief Scientific Officer | 2021-11-05 | Sale | 6.0 | $20.7 |
| Russell Alan J | Chief Scientific Officer | 2021-11-04 | Sale | 7,392.0 | $19.76 |
| Russell Alan J | Chief Scientific Officer | 2021-11-03 | Sale | 1,119.0 | $19.42 |
| Russell Alan J | Chief Scientific Officer | 2021-11-03 | Sale | 4,243.0 | $18.84 |
| Russell Alan J | Chief Scientific Officer | 2021-11-03 | Sale | 20,822.0 | $17.98 |
| Russell Alan J | Chief Scientific Officer | 2021-11-02 | Sale | 17,519.0 | $17.43 |
| Russell Alan J | Chief Scientific Officer | 2021-11-01 | Sale | 469.0 | $18.02 |
| Russell Alan J | Chief Scientific Officer | 2021-10-15 | Sale | 126.0 | $18.0 |
| Russell Alan J | Chief Scientific Officer | 2021-10-15 | Sale | 1,307.0 | $18.13 |
| Russell Alan J | Chief Scientific Officer | 2021-10-14 | Sale | 5,749.0 | $18.18 |
| Russell Alan J | Chief Scientific Officer | 2021-10-11 | Sale | 1,270.0 | $18.02 |
| Russell Alan J | Chief Scientific Officer | 2021-10-08 | Sale | 5,902.0 | $18.15 |
| Russell Alan J | Chief Scientific Officer | 2021-10-07 | Sale | 13,018.0 | $18.56 |
| Russell Alan J | Chief Scientific Officer | 2021-10-06 | Sale | 2,108.0 | $18.03 |
| Russell Alan J | Chief Scientific Officer | 2021-10-05 | Sale | 5,404.0 | $18.26 |
| Russell Alan J | Chief Scientific Officer | 2021-10-04 | Sale | 100.0 | $18.0 |
| Russell Alan J | Chief Scientific Officer | 2021-10-01 | Sale | 274.0 | $18.0 |
| Russell Alan J | Chief Scientific Officer | 2021-09-29 | Sale | 618.0 | $17.47 |
| Russell Alan J | Chief Scientific Officer | 2021-09-29 | Sale | 11,226.0 | $16.83 |
| Russell Alan J | Chief Scientific Officer | 2021-09-28 | Sale | 14,610.0 | $17.3 |
| Russell Alan J | Chief Scientific Officer | 2021-09-27 | Sale | 17.0 | $18.48 |
| Russell Alan J | Chief Scientific Officer | 2021-09-27 | Sale | 11,594.0 | $17.98 |
| Russell Alan J | Chief Scientific Officer | 2021-09-24 | Sale | 20,100.0 | $18.16 |
| Russell Alan J | Chief Scientific Officer | 2021-09-23 | Sale | 5,072.0 | $19.42 |
| Russell Alan J | Chief Scientific Officer | 2021-09-23 | Sale | 21,763.0 | $18.34 |
| ROOT JONATHAN D | Director | 2021-03-30 | Purchase | 15,625.0 | $16.0 |
| Thompson Peter A. | Director,TenPercentOwner | 2021-03-30 | Purchase | 312,500.0 | $16.0 |
| Thompson Peter A. | Director,TenPercentOwner | 2021-03-30 | Purchase | 46,875.0 | $16.0 |
| ORBIMED ADVISORS LLC | Director,TenPercentOwner | 2021-03-30 | Purchase | 312,500.0 | $16.0 |
| OrbiMed Capital GP VI LLC | Director,TenPercentOwner | 2021-03-30 | Purchase | 312,500.0 | $16.0 |
| OrbiMed Genesis GP LLC | Director,TenPercentOwner | 2021-03-30 | Purchase | 312,500.0 | $16.0 |
| ORBIMED ADVISORS LLC | Director,TenPercentOwner | 2021-03-30 | Purchase | 46,875.0 | $16.0 |
| OrbiMed Capital GP VI LLC | Director,TenPercentOwner | 2021-03-30 | Purchase | 46,875.0 | $16.0 |
| OrbiMed Genesis GP LLC | Director,TenPercentOwner | 2021-03-30 | Purchase | 46,875.0 | $16.0 |
| Novo Holdings A/S | TenPercentOwner | 2021-03-30 | Purchase | 625,000.0 | $16.0 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | TenPercentOwnerOther | 2021-03-30 | Purchase | 625,000.0 | $16.0 |
| Flynn James E | TenPercentOwnerOther | 2021-03-30 | Purchase | 625,000.0 | $16.0 |
| Deerfield Private Design Fund IV, L.P. | TenPercentOwnerOther | 2021-03-30 | Purchase | 625,000.0 | $16.0 |
| Deerfield Mgmt IV, L.P. | TenPercentOwnerOther | 2021-03-30 | Purchase | 625,000.0 | $16.0 |